India

Efforts to stem Europe’s scientific brain drain could be undermined by pay, as purchasing power dips below India and the EU–US gap widens further.

India’s biotech sector is powering ahead, with 30 per cent annual growth over the past four years. But venture capitalists are still not tempted to invest.

The US biotechnology industry has gone through more than three years of sustained IPO financings, but that news isn’t all rosy for the industry.

The Indian economy may be drawing nervous glances from Europe but its universities, famous for churning out 2.5 million graduates every year, are faltering.

Cambridge Biostability, a developer of temperature-stable liquid vaccines, agreed a joint venture with Panacea Biotec of India.

The German Research Foundation has opened an office in India, and is to introduce a new collaborative programme with its Indian counterpart next year.

Time and money are driving the world’s pharmaceutical companies east for their clinical trials. With its huge population, new helpful regulations and growth outstripping China, India plans to become the world leader in the clinical research business by the end of the decade.